Literature DB >> 27291521

Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Valery L Feigin1, Gregory A Roth2, Mohsen Naghavi2, Priya Parmar3, Rita Krishnamurthi3, Sumeet Chugh2, George A Mensah4, Bo Norrving5, Ivy Shiue6, Marie Ng2, Kara Estep2, Kelly Cercy2, Christopher J L Murray2, Mohammad H Forouzanfar2.   

Abstract

BACKGROUND: The contribution of modifiable risk factors to the increasing global and regional burden of stroke is unclear, but knowledge about this contribution is crucial for informing stroke prevention strategies. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the population-attributable fraction (PAF) of stroke-related disability-adjusted life-years (DALYs) associated with potentially modifiable environmental, occupational, behavioural, physiological, and metabolic risk factors in different age and sex groups worldwide and in high-income countries and low-income and middle-income countries, from 1990 to 2013.
METHODS: We used data on stroke-related DALYs, risk factors, and PAF from the GBD 2013 Study to estimate the burden of stroke by age and sex (with corresponding 95% uncertainty intervals [UI]) in 188 countries, as measured with stroke-related DALYs in 1990 and 2013. We evaluated attributable DALYs for 17 risk factors (air pollution and environmental, dietary, physical activity, tobacco smoke, and physiological) and six clusters of risk factors by use of three inputs: risk factor exposure, relative risks, and the theoretical minimum risk exposure level. For most risk factors, we synthesised data for exposure with a Bayesian meta-regression method (DisMod-MR) or spatial-temporal Gaussian process regression. We based relative risks on meta-regressions of published cohort and intervention studies. Attributable burden for clusters of risks and all risks combined took into account evidence on the mediation of some risks, such as high body-mass index (BMI), through other risks, such as high systolic blood pressure (SBP) and high total cholesterol.
FINDINGS: Globally, 90·5% (95% UI 88·5-92·2) of the stroke burden (as measured in DALYs) was attributable to the modifiable risk factors analysed, including 74·2% (95% UI 70·7-76·7) due to behavioural factors (smoking, poor diet, and low physical activity). Clusters of metabolic factors (high SBP, high BMI, high fasting plasma glucose, high total cholesterol, and low glomerular filtration rate; 72·4%, 95% UI 70·2-73·5) and environmental factors (air pollution and lead exposure; 33·4%, 95% UI 32·4-34·3) were the second and third largest contributors to DALYs. Globally, 29·2% (95% UI 28·2-29·6) of the burden of stroke was attributed to air pollution. Although globally there were no significant differences between sexes in the proportion of stroke burden due to behavioural, environmental, and metabolic risk clusters, in the low-income and middle-income countries, the PAF of behavioural risk clusters in males was greater than in females. The PAF of all risk factors increased from 1990 to 2013 (except for second-hand smoking and household air pollution from solid fuels) and varied significantly between countries.
INTERPRETATION: Our results suggest that more than 90% of the stroke burden is attributable to modifiable risk factors, and achieving control of behavioural and metabolic risk factors could avert more than three-quarters of the global stroke burden. Air pollution has emerged as a significant contributor to global stroke burden, especially in low-income and middle-income countries, and therefore reducing exposure to air pollution should be one of the main priorities to reduce stroke burden in these countries. FUNDING: Bill & Melinda Gates Foundation, American Heart Association, US National Heart, Lung, and Blood Institute, Columbia University, Health Research Council of New Zealand, Brain Research New Zealand Centre of Research Excellence, and National Science Challenge, Ministry of Business, Innovation and Employment of New Zealand.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27291521     DOI: 10.1016/S1474-4422(16)30073-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  370 in total

1.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

2.  Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

Authors:  Oleh Lushchak; Veronika Piskovatska; Olha Strilbytska; Iryna Kindrat; Nadya Stefanyshyn; Alexander Koliada; Volodymyr Bubalo; Kenneth B Storey; Alexander Vaiserman
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke.

Authors:  Ruslan Rust; Lisa Grönnert; Christina Gantner; Alinda Enzler; Geertje Mulders; Rebecca Z Weber; Arthur Siewert; Yanuar D P Limasale; Andrea Meinhardt; Michael A Maurer; Andrea M Sartori; Anna-Sophie Hofer; Carsten Werner; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 4.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

5.  Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).

Authors:  R Bijker; A Jiamsakul; E Uy; N Kumarasamy; R Ditango; R Chaiwarith; W W Wong; A Avihingsanon; L P Sun; E Yunihastuti; S Pujari; C D Do; T P Merati; P Kantipong; K V Nguyen; A Kamarulzaman; F Zhang; M P Lee; J Y Choi; J Tanuma; O T Ng; Blh Sim; J Ross; S Kiertiburanakul
Journal:  HIV Med       Date:  2019-01-08       Impact factor: 3.180

Review 6.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

7.  Submicron particle number doses in the human respiratory tract: implications for urban traffic and background environments.

Authors:  Aristeidis Voliotis; Constantini Samara
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-01       Impact factor: 4.223

8.  Residential Proximity to Major Roadways and Risk of Incident Ischemic Stroke in NOMAS (The Northern Manhattan Study).

Authors:  Erin R Kulick; Gregory A Wellenius; Amelia K Boehme; Ralph L Sacco; Mitchell S Elkind
Journal:  Stroke       Date:  2018-03-14       Impact factor: 7.914

9.  The protective effect of uric acid in reducing TLR4/NF-κB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro.

Authors:  Guan-Mei Cheng; Ruo-Lu Wang; Bin Zhang; Xiao-Ying Deng
Journal:  Mol Biol Rep       Date:  2020-02-24       Impact factor: 2.316

10.  N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.

Authors:  Gerald Chi; James L Januzzi; Serge Korjian; Yazan Daaboul; Samuel Z Goldhaber; Adrian F Hernandez; Russell D Hull; Alex Gold; Alexander T Cohen; Robert A Harrington; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.